Gooch & Housego (GHH) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
11 Mar, 2026Deal rationale and strategic fit
Acquisition of Global Photonics for $17.5 million accelerates expansion into the U.S. aerospace and defense market, mirroring a successful UK strategy and enhancing North American growth channels.
Establishes a full optical systems engineering and manufacturing hub in Tampa, Florida, leveraging a local photonics cluster and talent pipeline.
Adds advanced optical systems, laser protection, and photolithography expertise, meeting demand for U.S.-made defense solutions.
Strengthens relationships with U.S. defense primes and supports demand for domestically produced defense optics.
Complements existing manufacturing with deep application expertise and supports mid-teen returns.
Financial terms and conditions
Total consideration is $17.5 million, split equally between $8.75 million in cash (from existing debt facility) and $8.75 million in newly issued shares.
Sellers are subject to a 12-month lock-in on new shares, which they preferred and would have taken more.
Funded from existing resources; share count based on market price prior to completion.
Transaction expected to close by end of May, with marginal earnings enhancement in FY2025 and greater impact in subsequent years.
Global Photonics FY2024 revenue was $11.1 million, adjusted EBITDA $1.8 million, gross assets $4.1 million.
Synergies and expected cost savings
Revenue synergies expected by combining commercial pipelines and leveraging scalable U.S. manufacturing capacity.
Cost synergies anticipated through procurement and supply chain collaboration across North America and Europe.
Tampa facility can scale production 3–5 times current output, supporting future growth.
Capability and know-how enhancement through integration, especially in laser protection and complex optical design.
Latest events from Gooch & Housego
- Revenue up, profit down; strong order book and A&D/Life Sciences offset industrial weakness.GHH
H2 202411 Mar 2026 - Revenue and profit fell, but improved margins and a strong order book support a positive outlook.GHH
H1 202411 Mar 2026 - Revenue and profit surged, led by A&D and Life Sciences, with strong order cover for FY2025.GHH
H1 202511 Mar 2026 - Double-digit revenue and profit growth driven by A&D and acquisitions, with a record order book.GHH
H2 202511 Mar 2026 - Solid FY2024 results and acquisitions set the stage for growth in Life Sciences and Defence.GHH
Investor presentation11 Mar 2026 - Order book grew to £126.4M, driven by innovation, acquisitions, and operational improvements.GHH
AGM 2025 presentation11 Mar 2026 - Double-digit revenue growth and record order intake driven by A&D and new technology focus.GHH
AGM 2026 presentation11 Mar 2026 - Revenue delays impact FY2024, but strategic progress and FY2025 outlook remain strong.GHH
Trading update11 Mar 2026 - Strong second half trading and robust cash generation position the group for next year's recovery.GHH
Trading update11 Mar 2026